Mst 10 (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Mst 10, is an opioid analgesic presented as an oral formulation for oral use. It is employed to treat moderate to severe acute pain, postoperative pain, and cancer‑related pain in adult patients.

GNH USA supplies Mst 10 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Morphine sulfate is an opioid analgesic used to manage pain conditions that involve the central nervous system.

- Moderate to severe acute pain: provides rapid analgesia to reduce pain intensity in acute injury or illness. - Postoperative pain: controls pain following surgical procedures, facilitating recovery and mobilization. - Cancer pain: alleviates persistent malignant pain, improving quality of life in oncology patients.

Morphine sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Sweating - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic or severe allergic reaction - Adrenal insufficiency - Dependence or addiction - QT interval prolongation

When prescribing morphine sulfate, clinicians should observe several safety measures to minimize risk.

- Assess pain severity and treatment goals: tailor therapy to individual needs. - Evaluate renal and hepatic function: adjust dose in impairment. - Monitor respiratory status: watch for signs of depression, especially after dose changes. - Use the lowest effective dose for the shortest duration required. - Avoid concurrent use with other central nervous system depressants unless medically justified. - Store at ambient temperature: keep in original container, protect from moisture and light.

Morphine sulfate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent use with other opioids: increases risk of respiratory depression and overdose. - Benzodiazepines or other CNS depressants: synergistic sedation and respiratory effects. - Monoamine oxidase inhibitors (MAOIs): may precipitate severe hypertension or serotonin syndrome. - Respiratory depressants such as barbiturates: potentiate respiratory compromise. - Alcohol: enhances sedative effects and respiratory risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise morphine plasma levels. - CYP2D6 inhibitors (e.g., fluoxetine): can affect metabolism of certain opioids. - Diuretics: may increase risk of hypotension. - Anticholinergic agents: may worsen constipation. - Antihistamines: may add to drowsiness.